| Dana P Rabideau, MD | |
|
1500 Dodson Ave, Ste 280, Fort Smith, AR 72901-5182 | |
| (479) 709-7480 | |
| (479) 709-7479 |
| Full Name | Dana P Rabideau |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 1500 Dodson Ave, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710974548 | NPI | - | NPPES |
| 105851001 | Medicaid | AR | |
| 100221460A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | N6097 (Arkansas) | Primary |
| 207RN0300X | Internal Medicine - Nephrology | 15018 (Oklahoma) | Secondary |
| Entity Name | Fort Smith Hma Pbc Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477888907 PECOS PAC ID: 8224172127 Enrollment ID: O20100216000383 |
News Archive
Insurers report that a small number of people are enrolling in coverage through the federal insurance exchange, but the government has declined to release any numbers. Meanwhile, the federal government scrambles to make fixes as experts debate whether the glitches are a result of the high level of consumer interest or if other issues are at work.
Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative, today announced that they have entered into an exclusive collaboration to support the discovery and development of novel therapies for Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD).
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
In the first three years of Medicaid expansion due to the Affordable Care Act, the number of patients with end-stage kidney disease who died within a year of starting dialysis decreased in states that expanded Medicaid compared to non-expansion states, new research found.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dana P Rabideau, MD Po Box 402319, Atlanta, GA 30384-2319 Ph: (479) 709-7399 | Dana P Rabideau, MD 1500 Dodson Ave, Ste 280, Fort Smith, AR 72901-5182 Ph: (479) 709-7480 |
News Archive
Insurers report that a small number of people are enrolling in coverage through the federal insurance exchange, but the government has declined to release any numbers. Meanwhile, the federal government scrambles to make fixes as experts debate whether the glitches are a result of the high level of consumer interest or if other issues are at work.
Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative, today announced that they have entered into an exclusive collaboration to support the discovery and development of novel therapies for Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD).
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
In the first three years of Medicaid expansion due to the Affordable Care Act, the number of patients with end-stage kidney disease who died within a year of starting dialysis decreased in states that expanded Medicaid compared to non-expansion states, new research found.
› Verified 6 days ago
Dr. David A Hebert, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 7301 Rogers Ave, Fort Smith, AR 72903 Phone: 479-314-6000 | |
Christopher Brian Cross, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-3200 Fax: 479-274-3289 | |
Fiorella Nawar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1001 Towson Ave, Fort Smith, AR 72901 Phone: 479-709-7402 | |
Charles Moussallem, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1500 Dodson Ave, Suite 280, Fort Smith, AR 72901 Phone: 479-709-7480 Fax: 479-709-7479 | |
Dr. Jason Glenn Daily, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-4000 Fax: 479-274-4099 | |
Ongkarn Sarasombath, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-2000 Fax: 479-274-2194 | |
Dr. Jacob K Joseph, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-3200 Fax: 479-274-3289 |